1955 Capital
Venture capitalPre-Seed–Series A · 6 people tracked
Investment thesis
1955 Capital addresses the funding gap between scientific discovery and company creation, targeting emerging technologies in energy, biology, food systems, and computation that traditional investors overlook. The firm believes defining companies of the next era are currently being created from overlooked science, requiring operator-led approaches and close partnership from earliest stages to accelerate translation from lab to scale.
Source: firm website, verified Jul 21, 2026.
Team · 6 people
from the firm's websiteAndrew Chung founded 1955 Capital after serving as a General Partner at Khosla Ventures and investor at Lightspeed Ventures, bringing experience in early-stage deep technology investing.
What they invest in
from 4 of 18 portfolio companiesBiotech ×2AgTech ×1AI & Machine Learning ×1Cleantech ×1Climate Tech ×1Energy ×1FoodTech ×1Hardware ×1
HQs:United States×2Japan×1
Investments · 18 tracked
founders shown can be your intro pathLiquid biopsy technology enabling low cost, early cancer screening
Ampaire develops hybrid-electric propulsion systems for aircraft, with the AmpDrive technology deployed across multiple aircraft types to reduce fuel consumption, maintenance costs, and noise emissions. The company targets the aviation industry with technology designed for scaling from current hybrid-electric operations to future mass-market electric aircraft.
CleantechClimate TechEnergyHardwareSpace TechLos Angeles, US
Hybrid/electric propulsion for aviation and electric jet manufacturing
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
AI & Machine LearningBiotechMedical DevicesTokyo, JP
Non-invasive urine based diagnostic platform for early cancer detection
CropCoat produces a nontoxic coating solution for crops that leaves no residue and does not affect crop quality or taste, designed for growers seeking safer alternatives with no tolerance restrictions for export.
AgTech
Environmentally friendly materials platform to protect crops from pests
Combining cost & safety of lead-acid and performance & lifetime of Li-ion
Protein platform to produce tasty products across all food groups
The Fynder Group develops a biotechnology platform using extremophile fungi to produce specialty ingredients, biopharmaceutical drugs, and bio-based materials for food, beverage, pharmaceutical, and textile applications. The company leverages proprietary filamentous fungal strains to engineer high-performance solutions across multiple industries.
BiotechFoodTechNew MaterialsChicago, US
FDA-approved next-gen robots that improve clinical outcomes
Advanced materials for auto and construction markets
3D printing for industrial applications and heavy manufacturing
Developers of advanced, low-emission railway propulsion platform
All-in-one blood diagnostic platform for distributed or in-home use
Producer of high-value chemicals through waste slag upcycling
Frequently asked questions
- What stage does 1955 Capital invest at?
- 1955 Capital invests at the Pre-Seed, Seed, Series A stages.
- What sectors does 1955 Capital focus on?
- 1955 Capital focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Data & Infrastructure, Deep Tech, Energy, FoodTech, Healthtech, Medical Devices, New Materials, Robotics.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Everywhere Ventures is an early-stage venture capital firm that backs founders across all sectors and geographies. The firm invests in pre-seed and seed stage companies and is known for providing high-value support to founders through its active investor community of LPs who are themselves founders and operators.
Snatched Ventures is an investment firm focused on identifying and supporting transformative entrepreneurs pursuing breakthrough innovations across multiple sectors.
Refactor backs hard technology companies built on physical atoms rather than digital applications. The firm writes initial checks of $1-2M and has deployed five funds with approximately $50M in total size.
A venture capital firm partnering with pre-seed and seed stage founders addressing major global challenges. The firm provides hands-on support across business launch, go-to-market strategy, fundraising, and marketing.